Citigroup
NNVC icon

Citigroup’s NanoViricides NNVC Stock Holding History

Citigroup’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$1 – 6244
2025
Q4 		$1 Sell
1
-5,265
-100% -$7.39K ﹤0.01% 5980
2025
Q3 		$7.53K Buy
+5,266
New +$7.88K ﹤0.01% 5098
2020
Q4 		– Sell
-936
Closed -$4K – 7544
2020
Q3 		$4K Sell
936
-542
-37% -$2.97K ﹤0.01% 7132
2020
Q2 		$11K Buy
+1,478
New +$10.3K ﹤0.01% 7007
2016
Q2 		– Sell
-12
Closed -$1K – 7297
2016
Q1 		$1K Sell
12
-10
-45% -$388 ﹤0.01% 7316
2015
Q4 		$1K Buy
+22
New +$527 ﹤0.01% 7397
2015
Q3 		– Sell
-1
Closed – – 7593
2015
Q2 		$0 Sell
1
-135
-99% -$5.14K ﹤0.01% 7666
2015
Q1 		$6K Sell
136
-232
-63% -$12.4K ﹤0.01% 6663
2014
Q4 		$20K Buy
368
+285
+343% +$18.9K ﹤0.01% 6212
2014
Q3 		$5K Buy
83
+66
+388% +$5.18K ﹤0.01% 6559
2014
Q2 		$1K Buy
+17
New +$1.21K ﹤0.01% 6934
2014
Q1 		– Sell
-44
Closed -$4K – 7137
2013
Q4 		$4K Buy
+44
New +$4.53K ﹤0.01% 6665

Other funds holding NNVC

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Miller Financial Services Marshall, Michigan $91.3M AUM 21.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citigroup's NNVC Position: Q1 2026 in Review

Citigroup sold out of NanoViricides (NNVC) in Q1 2026, closing a stake of 1 share — an estimated $1 sold.

Citigroup first reported a position in NNVC in Q4 2013 and held it in 12 quarters. The position peaked at $20K in Q4 2014. 48 funds tracked by Wall St. Rank hold NNVC as of Q1 2026.

  • Citigroup reported no remaining NanoViricides position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 1 NanoViricides share in Q1 2026, an estimated $1.
  • Citigroup first reported a position in NanoViricides in Q4 2013 and held it in 12 quarters.
  • Citigroup's NanoViricides position peaked at $20K in Q4 2014.
  • 48 funds tracked by Wall St. Rank held NanoViricides as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.